3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
9
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Mouth Neoplasms
3
Carcinoma, Intraductal, Noninfiltrating
2
Breast Carcinoma In Situ
2
Uterine Cervical Neoplasms
1
Sentinel Lymph Node Biopsy (SLNB)
1
Sarcoidosis, Pulmonary
1
Sarcoidosis
1
Rhabdomyosarcoma
1
Recurrence
1
Recurent Vulvar Carcinoma
1
Rectal Neoplasms
1
Pancreatic Neoplasms
1
Melanoma
1
Lymphoma
1
Lymphatic Metastasis
1
Lung Neoplasms
1
HIV Infections
1
FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma
1
Eyelid Sebaceous Gland Carcinoma
1
Cervical Adenocarcinoma
1
Carcinoma, Ductal
1
Anus Neoplasms
1
Interventions
Paclitaxel
40
Carboplatin
34
Bevacizumab
29
liposomal doxorubicin
20
Specimen Handling
18
Taxes
17
olaparib
16
Magnetic Resonance Spectroscopy
16
pembrolizumab
15
Gemcitabine
15
Topotecan
13
Immunoglobulin G
11
Disulfides
11
Biopsy
11
mirvetuximab soravtansine
8
niraparib
7
Nivolumab
7
Doxorubicin
7
Cyclophosphamide
6
Cisplatin
6
Drug Therapy
5
130-nm albumin-bound paclitaxel
5
cemiplimab
4
cediranib
4
Letrozole
4
Injections
4
Docetaxel
4
1-dodecylpyridoxal
4
sarilumab
3
rucaparib
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Fallopian Tube Neoplasms
×
Sentinel Lymph Node Biopsy
×
1 year
×
Clear all
No trials found.